RELZIQ Trademark

Trademark Overview


On Friday, July 22, 2005, a trademark application was filed for RELZIQ with the United States Patent and Trademark Office. The USPTO has given the RELZIQ trademark a serial number of 78676399. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, July 12, 2007. This trademark is owned by Eli Lilly and Company. The RELZIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medicinal preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous system diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, and urological disorders
relziq

General Information


Serial Number78676399
Word MarkRELZIQ
Filing DateFriday, July 22, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, July 12, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2006

Trademark Statements


Goods and ServicesPharmaceutical and medicinal preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous system diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, and urological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 29, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Friday, December 28, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Friday, December 7, 2007ABANDONMENT - NO USE STATEMENT FILED
Friday, March 16, 2007EXTENSION 1 GRANTED
Monday, January 8, 2007EXTENSION 1 FILED
Monday, January 8, 2007TEAS EXTENSION RECEIVED
Friday, September 15, 2006ASSIGNED TO EXAMINER
Tuesday, July 11, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 18, 2006PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2006NOTICE OF PUBLICATION
Thursday, March 2, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 24, 2006ASSIGNED TO LIE
Friday, February 17, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 17, 2006EXAMINER'S AMENDMENT ENTERED
Friday, February 17, 2006EXAMINERS AMENDMENT E-MAILED
Friday, February 17, 2006EXAMINERS AMENDMENT -WRITTEN
Thursday, February 9, 2006ASSIGNED TO EXAMINER
Friday, July 29, 2005NEW APPLICATION ENTERED IN TRAM